Attila Andor

Articles

Article: INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE. 2024;26:100564
Evaluating the amoeba thioredoxin reductase selenoprotein as potential drug target for treatment of Acanthamoeba infections
Loufouma-Mbouaka A; Andor A; Leitsch D; Perez-Serrano J; Arner ESJ; Walochnik J; Martin-Perez T
Article: REDOX BIOLOGY. 2023;67:102897
TXNL1 has dual functions as a redox active thioredoxin-like protein as well as an ATP- and redox-independent chaperone
Andor A; Mohanraj M; Pato ZA; Uri K; Biri-Kovacs B; Cheng Q; Arner ESJ
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2006;72(10):6554-6559
Generation of useful insertionally blocked sterol degradation pathway mutants of fast-growing mycobacteria and cloning, characterization, and expression of the terminal oxygenase of the 3-ketosteroid 9alpha-hydroxylase in Mycobacterium smegmatis mc(2)155.
Andor A; Jekkel A; Hopwood DA; Jeanplong F; Ilkoy E; Kónya A; Kurucz I; Ambrus G
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2006;346(1):45-50
Inhibition of the MDR1 transporter by new phenothiazine derivatives.
Kónya A; Andor A; Sátorhelyi P; Németh K; Kurucz I